Sixty-six ambulatory postmenopausal women with osteoporosis were enrolled at 15 study sites having multi-detector row CT , and included women injected with teriparatide ( n = 29 , 74.2 5.1 years ) or with placebo ( n = 37 , 74.8 5.3 years ) .